IMDX peer analysis
IMDX (IMDX) against its competitors: price, today's move, 1-year return and market value side by side.
- IMDX's peers: ARMP (Armata Pharmaceuticals), CCCC (C4 Therapeutics), CDXS (Codexis), IVVD (Invivyd), MIST (Milestone Pharmaceuticals), OABI (OmniAb), PEPG (PepGen), PRLD (Prelude Therapeutics Incorporated).
IMDX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARMP Armata Pharmaceuticals | $2.98 | -5.99% | -59.18% | $110.83M |
| CCCC C4 Therapeutics | $2.37 | -2.86% | -5.19% | $311.26M |
| CDXS Codexis | $1.05 | -8.70% | -35.19% | $115.08M |
| IVVD Invivyd | $0.43 | -3.57% | -82.80% | $127.12M |
| MIST Milestone Pharmaceuticals | $0.40 | -13.27% | -82.86% | $49.71M |
| OABI OmniAb | $4.64 | -7.82% | 181.01% | $676.30M |
| PEPG PepGen | $3.79 | -3.56% | -31.46% | $262.50M |
| PRLD Prelude Therapeutics Incorporated | $3.22 | -1.08% | 92.81% | $257.83M |
| IMDX Insight Molecular Diagnostics | $1.66 | 4.40% | -72.33% | $54.38M |